玻璃体视网膜淋巴瘤患者房水中MYD88 L265P突变检测
该前瞻性研究纳入8例细胞学确诊的双眼玻璃体视网膜淋巴瘤患者(16眼),检测房水与玻璃体中MYD88 L265P突变。结果显示6例(75%)患者房水突变阳性,玻璃体检测的6例全部阳性;非感染性葡萄膜炎对照组房水均为阴性。提示房水MYD88突变检测可作为该病辅助诊断工具。
要点
- 细胞学确诊的玻璃体视网膜淋巴瘤患者中,75%房水可检出MYD88 L265P突变。
- 玻璃体检测的6例患者全部阳性,房水与玻璃体结果在8眼中7眼一致。
- 非感染性葡萄膜炎对照组房水MYD88 L265P突变均为阴性。
核心结论
- 细胞学确诊的玻璃体视网膜淋巴瘤患者中,75%的房水可检测到MYD88 L265P突变,可作为辅助诊断手段。
研究设计与样本
- 前瞻性纳入8例细胞学确诊的双眼玻璃体视网膜淋巴瘤患者(16眼),平均年龄69.5岁(范围50-85岁)。
- 房水穿刺后提取基因组DNA,诊断性玻璃体切除后提取玻璃体样本DNA,采用扩增阻滞突变系统PCR和焦磷酸测序检测MYD88 codon 265突变。
- 对照组为8例年龄匹配的非感染性葡萄膜炎患者,检测房水MYD88 L265P突变。
主要发现
- 玻璃体检测的6例患者MYD88 L265P全部阳性,除1例样本外与细胞学检查结果一致。
- 6例患者(75%)房水检出MYD88 L265P突变,其中3例双眼均阳性。
- 房水与玻璃体MYD88 L265P结果在8眼中有7眼一致。
- 非感染性葡萄膜炎对照组房水MYD88 L265P突变检测均为阴性。
临床怎么用
- 对细胞学确诊的玻璃体视网膜淋巴瘤患者,房水MYD88 L265P突变检测可作为附加诊断工具。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To detect the presence of MYD88 L265P mutation in the aqueous humor of patients with cytologically proven vitreoretinal lymphoma. METHODS: Eight consecutive patients with bilateral vitreoretinal lymphoma (16 eyes) were prospectively evaluated. Genomic DNA was extracted from aqueous samples after paracentesis and vitreous humor samples after diagnostic vitrectomy. MYD88 codon 265 mutation was investigated by both amplification-refractory mutation system polymerase chain reaction approach and pyrosequencing assay in the aqueous humor of all patients and in the vitreous of 6 patients. A control group of 8 age-matched patients with established diagnosis of noninfectious uveitis was also tested for the presence of MYD88 L265P mutation in the aqueous humor. RESULTS: Eight patients (three men, five women) with mean age of 69.5 years (range 50-85 years) were considered. All the patients tested for MYD88 L265P in the vitreous (six) were positive, and this result was consistent with cytological examination in all samples but one. The MYD88 L265P mutation was found in the aqueous of 6 patients (75%), and in 3 of them, the mutation was present in both eyes. Results of MYD88 L265P mutation in aqueous and vitreous sample were consistent in 7 of the 8 eyes with available samples. The aqueous humor of the noninfectious uveitis control group was negative for the detection of MYD88 L265P mutation. CONCLUSION: MYD88 mutation was detected in the aqueous humor of 75% of patients with cytologically proven vitreoretinal lymphoma. This technique may be considered as an additional diagnostic tool in the detection of the disease.
引用
- Miserocchi E, Ferreri AJM, Giuffrè C, et al. MYD88 L265P MUTATION DETECTION IN THE AQUEOUS HUMOR OF PATIENTS WITH VITREORETINAL LYMPHOMA. Retina. 2019. PMID: 30204732. doi:10.1097/IAE.0000000000002319
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。